Renal Osteodystrophy (ROD), the bone component of CKD-mineral bone disorder (CKD-MBD3), is traditionally assessed using histomorphometry, with high turnover bone disease treated by reducing parathyroid hormone (PTH) with calcitriol or calcimimetics. The gene discussed is PTH; the disease is chronic kidney disease.